+ All Categories
Home > Documents > Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides...

Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides...

Date post: 11-Jan-2016
Category:
Upload: matthew-jacobs
View: 218 times
Download: 0 times
Share this document with a friend
56
Reporting System of Biocidal Vigilance Hend Al-Hussieny Hend Al-Hussieny BSc. Pharm, MSc. BSc. Pharm, MSc. Head of the Biocides Vigilance Head of the Biocides Vigilance Department Department Egyptian Drug Authority (EDA) Egyptian Drug Authority (EDA) Egyptian Pharmaceutical Vigilance Egyptian Pharmaceutical Vigilance Center (EPV Center (EPVC) Biocides Vigilance Department (BVD) Biocides Vigilance Department (BVD)
Transcript
Page 1: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Reporting System of

Biocidal Vigilance

Hend Al-HussienyHend Al-HussienyBSc. Pharm, MSc.BSc. Pharm, MSc.

Head of the Biocides Vigilance DepartmentHead of the Biocides Vigilance Department

Egyptian Drug Authority (EDA) Egyptian Drug Authority (EDA) Egyptian Pharmaceutical Vigilance Center (EPVEgyptian Pharmaceutical Vigilance Center (EPVC)

Biocides Vigilance Department (BVD)Biocides Vigilance Department (BVD)

Page 2: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Establishment

BVD has been established in the Egyptian Drug

Authority (EDA), Ministry of Health &

Population (MOHP) to be responsible for the

collection and evaluation of information on

biocidal products marketed in Egypt with

particular reference to adverse reactions

(Incidents). Furthermore, BVD is taking all

appropriate measures to

Page 3: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Aims of Reporting

1. Early detection of Adverse Reaction (Incident) & other problem

related to the use of Biocidal Products.

2. Detection of increased frequency of Adverse Reaction (Incident) .

3. Identification of predictors and possible mechanisms underlying

Adverse Reaction (Incident) .

4. Quantitative Estimation of risk/benefit profiles of Biocidal Products

and dissemination of information needed to improve  its use.

5. Prevention of preventable Adverse Reaction (Incident) .

6. Encouraging rational and safe use of Biocidal Products.

7. Communication and dissemination with international institutions

working in Biocidal Products.

Page 4: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Biocidal Vigilance Rule

Page 5: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Reporting System

Page 6: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Spontaneous Reporting System Procedure

• A HCPs, MAHs or Users reports a suspected adverse

reaction (Incidents) related to one or more biocidal

products, to The (BVD).

• Reports are collected, collated, and validated by the

(BVD) and are usually entered into a database.

• The database is used to identify potential signals and

analyze data in order to clarify risk factors, apparent

changes in reporting profiles etc.

Page 7: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

N. B.

.

Page 8: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

How do I report the Biocidal Product incident?

You do not have to be certain that biocidal product caused the effect in

order to report it.

There are two ways you can report biocidal product incident:

1. The biocidal product company (MAHs) as listed on the product label. They

are required by ministerial decree to report all ARs (Incidents) related to

their products to BVD. Or,

2. BVD has biocidal products incident reporting forms (Blue Cards). Please

use the form of report to report the adverse reaction (incident) you face and

mail it to the address on the form. You must provide information about the

product (name, registration number or active ingredient found on the label)

and a description of the effect.

Page 9: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

What to report?

Page 10: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

How to submit Blue Card Report?

• After filling the blue card; All AR (Incident) reports can be sent to the BVD by:

1. Fax: Special number for the AR (Incident) reporting2. Postal mail (regular letters)3. E-mail : Special account for AR(Incident) reporting, [email protected]. By Hand: Contact person in hospitals, by biocidal

distribution companies….

There is collaboration between BVD and some biocidal distribution companies to participate in collecting the filled Pesticides Incident Safety Report (PISR) then forward them to BVD.

Page 11: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Serious reports: should be submitted in expedited

manner i.e. as soon as possible & no later than 15

calendar days

While other reports can be submitted on regular

basis (every month) by any means.

Page 12: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Spontaneous Reporting of Adverse Reactions (Incidents)

• The Spontaneous reporting structure is the voluntary and the

most common way through which the regulatory bodies collect

AR (incident) information for biocidal products once they are

on the market

Page 13: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

N. B.

We would like to confirm that there is no any legal

responsibility or any liability whatsoever on the reporter of

the ARs (Incidents), also the information in the report is

confidential and totally protected including both consumer

(user) and reporter identity. Moreover, this voluntarily

reporting help to evaluate the safety of the products

Page 14: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

How do I report the Biocidal Product incident?

You do not have to be certain that biocidal product caused the effect in order to report it.

There are two ways you can report biocidal product incident:

• The biocidal product company (MAHs) as listed on the product label. They are

required by ministerial decree to report all ARs (Incidents) related to their products to

BVD. Or,

• BVD has biocidal products incident reporting forms (Blue Cards). Antiseptic &

Disinfectants Incident Reporting Form and Pesticide Incident Reporting Form.

Please use the form of report to report the adverse reaction (incident) you face and mail it

to the address on the form. You must provide information about the product (name,

registration number or active ingredient found on the label) and a description of the

effect.

Page 15: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Benefits of reporting

• Improvement on the quality of care offered to users

• Reduction of biocidal product related problems leading to better

outcome

• Improved knowledge

• Access to feedback information on biocidal product related

problems reported within the country and internationally

• Satisfaction for the fulfillment of a moral and professional

obligation.

Page 16: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Confidentiality Statement

Any information related to the identity of persons will be

protected, any unsolicited information will be destroyed

Page 17: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• It is important to provide as much information as possible. The

more information collected, the better understanding (BVD) will

have of the incident.

Page 18: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• It is important to appreciate

• Firstly, that BVD database for IISRs & ADISRs can detect

duplicate reports. Therefore, if healthcare professional deems it

necessary to submit a report they should do so even if there is a

possibility that someone else might have done the same.

• Secondly, different people will include different information when

they complete a Blue Card, all of which is useful in creating a full

picture of the reaction that has taken place.

If there is not enough space provided for you to answer the

question, you may attach a separate sheet with the text on it

Page 19: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• How will the provided information be used by the BVD?

• We use all available information to assess if the biocidal product

was the cause of the reported effect. If so, we assess what the risk

to Egyptians is and how similar incidents can be prevented. We do

this by attempting to answer these questions:

Page 20: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• When and how did exposure happen?

• Are the effects expected?

• How many other incidents of this kind have been reported?

• How complete is the information in the report?

• Was the product used according to the label instructions?

• Is the product used a lot in Egypt?

Page 21: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Causality assessment• Causality assessment is the method by which the extent of

relationship between the biocidal product and a suspected reaction is established.

• Causality assessment• The evaluation of the likelihood that the biocidal product was the

causative agent of an observed adverse reaction (incident). Causality assessment is usually made according established algorithms.

Page 22: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• four sections to validate the biocidal product incident safety report

• An identifiable user

• An identifiable reporter

• Suspected Product

• Suspected adverse reaction (incident)

Page 23: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Seriousness of Adverse reactions (Incidents)

• A serious adverse event or reaction is any untoward medical

occurrence associated with the use of a biocidal product in a user

that, the consumer outcome is one of the following Examples of

serious Ars

• Death

• Life-Threatening?????????????????????

Page 24: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• As soon as possible

Reports on all suspected adverse reactions (incident) known or

not, serious or not are welcome and useful If there is any doubt

about whether or not it is an AR (incident); always it is best

practice to submit a report

Page 25: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Part I Antiseptic & Disinfectant Reporting Forms

Page 26: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

What to report?

• All suspected adverse reactions should be reported, especially

those that are:

• Unexpected, regardless of their severity, i.e., not consistent with

product information or labeling; or

• Serious, whether expected or not; or

• Reactions to recently marketed antiseptic & disinfectants

products, regardless of their nature or severity.

Page 27: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

What is a serious adverse reaction?

• A serious AR (Incident) is one that requires in-patient (user)

hospitalization or prolongation of existing hospitalization, causes

congenital malformation, results in persistent or significant

disability or incapacity, is life-threatening or results in death. ARs

that require significant medical intervention to prevent one of these

listed outcomes are also considered to be serious.

Page 28: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Requirements of Antiseptic & Disinfectants Incident Report Form (Blue Card)

• Patient’s Details: Name/ Initials (Optional), Sex (Male or

Female), Age & Weight in Kg.

• Suspected Antiseptic or Disinfectant(s):

Page 29: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Product name: Detailed name of suspected antiseptic or disinfectant must be provided.

• Was the product effective as an antiseptic or disinfectant or not?

• Active ingredient(s): The name of the active ingredient(s) of the suspected Antiseptic & Disinfectants. e.g. Hydrogen peroxide.

• Concentration: The name of active ingredient(s) of the suspected Antiseptic or Disinfectants should be provided.

• Minimum purity: This item referred to the extent of active ingredient(s) purity e.g. 97% -90%

• Product type: Either Antiseptic or Disinfectant. • Dilution: provide the dilution of the product if it is applicable

Page 30: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Uses of the suspected Antiseptic & Disinfectants:• • Disinfectant: Critical use, Semi critical use and Non critical use.• • Antiseptic: • a. Personal use: Personal Domestic use & Personal Commercial

use.• b. Professional use: Professional Healthcare & Food Premises.• Registration No.: Provide the product MOHP registration number:• Registration number examples: 2213/2011.

Page 31: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Type of registration: Provide the type of registration e.g. Local, Toll, Imported, Under license, Bulk or Toll.

• Frequency of use: Provide the frequency of use of the suspected Antiseptic or Disinfectants. Include the amount of Antiseptic & Disinfectants applied (application rate), the location that the Antiseptic & Disinfectants was applied to and the method of application. Application rate examples: 10 ml of Antiseptic & Disinfectants /100CM 3

.

Page 32: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Location of incident examples: Home, Hospital, Lab,………………………..etc.

• Method of application examples: Spray, Paint, Prose, Bait,………………… etc.

• Pharmaceutical form: Describe the type of formulation: e.g. Solution, Wipes, Foam, Spray, Gel, Shampoo, ………………………………………..…..…..….etc.

Page 33: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Type of Incident:

There are four types of incidents:

• Human Health Incident.

• Hard Surface Incident.

• Veterinary Incident.

• Medical device Incident.

Page 34: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

A- In case of Human Health – Incident:

• Describe what was exposed? • e.g. Eye, Skin, Oral, Respiratory (inhalation),

………………………………….. etc. • Describe all symptoms. Include the length of time the symptom(s)

lasted, the severity of the symptom(s), and how often the symptom(s) occurred. Also describe any medical treatment received, including medication prescribed, test results and length of hospitalization (if applicable).

• Examples of user's reaction to Antiseptic & Disinfectants exposure: e.g. Dizziness, Headache, Blurred vision, Convulsion, Nausea/Vomiting, Itching, …...….…..…. etc.

Page 35: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

B- In case of Hard Surface – Incident:

• Describe what was exposed: Floors, Benches, ……………………………….... etc.

• Describe what happened to surface: Spotting, Bleaching (discoloration), Whitening…………………………………………………………………………..etc.

• Describe how the incident happened, as well as any additional information concerning the incident:

Page 36: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

C- In case of Veterinary – Incident:

• Mention who was observing this incident; e.g. Animal owner, Veterinary professional, Witness, ….. etc.

• Describe all symptoms. Include the length of time the symptom(s) lasted, the severity of the symptom(s), and how often the symptom(s) occurred. Also describe any medical treatment that the animal received, including medication prescribed or test results.

• Provide No. of animals affected: • Mention the type of animal affected: Dog, Cat, Bird, Horse,

………….……...... etc.

• Describe how was the animal exposed to the antiseptic or disinfectant? Include the amount of product the animal was exposed to, and how long or how often the animal was exposed to it.

Page 37: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

D- In case of Medical device Incident:

• Describe the type of the medical device:

• Describe what the reaction was happened: Corrosion, Spotting,

Whitening,………………………etc.

Page 38: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Incident's Details:

• Describe symptom(s) that appeared: i.e. Itching, Severe headache that lasted for 2 days, Rash on forearms and hands that lasted 1 week. Saw doctor 2 days after incident and was given a prescription for medication X, Vomited 3 times, approximately every 2 hours, burning eyes………………………………Etc.

• Date of incident: Provide Day, Month & Year (dd/mm/yyyy).• Are you the first observer of the event? • Do the symptoms reappear after reusing the product?

• What was the outcome of the incident? Require Hospitalization, • Life threatening, Permanent disability, Died, Congenital

abnormalities, Required intervention to prevent damage,………………………….………..etc.

• Has this incident been reported to the manufacturer?

Page 39: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Reporter’s Details: The One who filled in this form: Patient,

Physician, Pharmacist, Nurse,

……………………………………………………………….

…..etc.

• Name: See confidentiality statement

• Specialty (If physician, Address: See confidentiality statement, E-

mail, Telephone/ Mobile, Date of reporting &Signature.

Page 40: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Any More Comments:

• Any additional information can be provided in this space, or on a

separate sheet.

• Confidentiality Statement: Any information related to the identity

of persons will be protected. Any unsolicited personal information

will be destroyed.

Page 41: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

PART (II) Pesticides Reporting Forms (Blue Card):

Page 42: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Consumer Product Safety

• Pesticides are tested and evaluated for environmental and health

risks before they are registered by the CAPA. However, some

adverse effects may not become evident until the product is used

under "real-life" circumstances. The information you are about to

report will provide the BVD with valuable data regarding potential

risks to humans from the use of pesticides in "real-life"

circumstances.

Page 43: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• If you require immediate medical attention, if you are experiencing symptoms, consult the First Aid instructions on the product label and contact your health care provider or call the nearest poison center. For environmental emergencies, contact your local authorities or the Biocidal Vigilance Department (BVD). All pesticides are tested and evaluated for safety before being registered for use by Egyptians. To continue to monitor for safety after they are registered, BVD collects pesticide incident reports from Egyptians.

Page 44: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Requirements of Pesticide Incident Reporting Form (Blue Card)

• Suspected Pesticide(s):• Product Name: Detailed name of suspected Pesticide must be

provided.• Active ingredient(s): The name of the active ingredient(s) of the

suspected Pesticide e.g. Deltamethrin • Product type: Public Health or House Hold • Uses: e.g. to control rodents, mosquito, ..………………………..

………...……etc. • Application rate: e.g. 10cm/100m2

• Location of incident: location where the incident occurred (see Confidentiality Statement) e.g. city, governorates

Page 45: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Type of formulation: e.g. Liquid, Wettable Powder (WP), Dustable powder (DP), Aerosol, Pellets/bait, Tablet (TB)/ Balls, Granules, …….......…..……..…….....etc.

• Method of application: Spray, Bait, Prose,……….….………………….…..…etc.

• Type of pack: Can, Aluminum sachet, Plastic ……………………………...…..etc.

• Is it registered at Ministry of Health: If Yes (Write the CAPA Registration No……….).

• Was the product effective as an pesticide: Yes or No

Page 46: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Patient Details (If the affected subject is human)

• Name/ Initials (Optional): Name/ Initials (Optional), Sex (Male

or Female), Age & Weight in Kg.

Page 47: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Types of Incident:• Human Health Incident: • What was exposed? E.g. Eye, Respiratory (inhalation), Skin,

……….…....etc. • 2- Domestic Animal Incident: No. of animals affected: e.g. 2,4,

……………..…etc. • Type of animal affected? i.e. cat, horse, chicken,

……………………….….etc. • Environmental Incident: What happened to the animal(s) or plant(s) after the initial observation?

• Packaging Incident: Was the pesticide in its original container or not?

• When did the packaging failure occur? e. g. During storage, Use of product, Transportation,………………………………………………………….………etc.

Page 48: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

A- In case of Human Health – Incident:

• Describe what was exposed? • Eye, Skin, Oral, Respiratory (inhalation),

………………………………...……….. etc. • Describe all symptoms. Include the length of time the symptom(s)

lasted, the severity of the symptom(s), and how often the symptom(s) occurred. Also describe any medical treatment received, including medication prescribed, test results and length of hospitalization (if applicable).

• Example of patient's reaction to pesticide exposure • Dizziness, Headache, Blurred vision, Convulsion,

Nausea/Vomiting, …….….….. etc.

Page 49: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

B- In case of Packaging Failure – Incident:

• Provide what was type of pack? • e.g. Can, Aluminum sachet, Plastic bottle , Glass,

……………………..….…….… etc. • Was the pesticide/chemical in its original container?• Provide when did the packaging failure occur? • e.g. (During storage, Use of product, Transportation,

………………….…………. etc.• Describe how the packaging failed, as well as any additional

information concerning the incident.

Page 50: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

C- In case of Domestic Animal – Incident: • Who is observing this incident?• e.g. Animal owner , Witness, Veterinary professional,

…………..….……….……. etc.• Describe all symptoms. Include the length of time the symptom(s)

lasted, the severity of the symptom(s), and how often the symptom(s) occurred. Also describe any medical treatment that the animal received, including medication prescribed or test results.

• No. of animals affected. e.g. 2animals, 30 animals, ……………………..………etc.

• Type of animal affected: Provide the type of affected animal, e.g. Cat, Bird, Horse…………………………………………………………………...………….. etc.

• How was the animal exposed to the pesticide? Include the amount of pesticide the

Page 51: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

animal was exposed to, and how long or how often the animal was

exposed to it.

Page 52: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

D- In case of Environmental Incident:

• Describe what happened to the animal(s) or plant(s) after the initial

observation?

• Provide the total number of animals or plants affected (estimate if

not counted)

• Provide were environmental samples collected and analyzed.

Page 53: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Incident's Details:

• Date incident occur: dd/mm/yyyy.• Are you the first observer of the event or not? • What was the outcome of the incident? i.e. Life threatening,

Hospitalization, Permanent Disability, Died, Required intervention to prevent Damage,…..……..etc.

• Has this incident been reported to the manufacturer or not?

• How was the person exposed to the pesticide? Include, if available, the amount of the pesticide the person was exposed to, and how long or how often the person was exposed to it

• Describe symptom(s) appeared & the date;

Page 54: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Reporter’s Details

• The one who filled in this form: Patient, Physician, Pharmacist,

Nurse,

…………………………………………………………………..etc.

• Name: See confidentiality statement

• Specialty (If physician, Address: See confidentiality statement, E-

mail, Telephone/ Mobile,

• Date of reporting &Signature.

Page 55: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

• Any More Comments:

• Any additional information can be provided in this space, or on a

separate sheet.

•  Confidentiality Statement: Any information related to the

identity of persons will be protected. Any unsolicited personal

information will be destroyed.

Page 56: Reporting System of Biocidal Vigilance Hend Al-Hussieny BSc. Pharm, MSc. Head of the Biocides Vigilance Department Egyptian Drug Authority (EDA) Egyptian.

Thank You


Recommended